These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20937616)

  • 1. Salvia divinorum use and phenomenology: results from an online survey.
    Sumnall HR; Measham F; Brandt SD; Cole JC
    J Psychopharmacol; 2011 Nov; 25(11):1496-507. PubMed ID: 20937616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.
    Zawilska JB; Wojcieszak J
    Hum Psychopharmacol; 2013 Sep; 28(5):403-12. PubMed ID: 23794315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvia divinorum: An overview of the usage, misuse, and addiction processes.
    Mahendran R; Lim HA; Tan JY; Chua SM; Winslow M
    Asia Pac Psychiatry; 2016 Mar; 8(1):23-31. PubMed ID: 26617400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).
    Bücheler R; Gleiter CH; Schwoerer P; Gaertner I
    Pharmacopsychiatry; 2005 Jan; 38(1):1-5. PubMed ID: 15706458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.
    Johnson MW; MacLean KA; Reissig CJ; Prisinzano TE; Griffiths RR
    Drug Alcohol Depend; 2011 May; 115(1-2):150-5. PubMed ID: 21131142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet.
    Xavier Moreira F; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Forensic Sci Int; 2014 Sep; 242():255-260. PubMed ID: 25093918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacology of the hallucinogenic sage Salvia divinorum.
    Prisinzano TE
    Life Sci; 2005 Dec; 78(5):527-31. PubMed ID: 16213533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida's ban.
    Stogner J; Khey DN; Griffin OH; Miller BL; Boman JH
    Int J Drug Policy; 2012 Nov; 23(6):512-21. PubMed ID: 22502947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From local to global-fifty years of research on Salvia divinorum.
    Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
    J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and post-acute behavioral and psychological effects of salvinorin A in humans.
    Addy PH
    Psychopharmacology (Berl); 2012 Mar; 220(1):195-204. PubMed ID: 21901316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use patterns and self-reported effects of Salvia divinorum: an internet-based survey.
    Baggott MJ; Erowid E; Erowid F; Galloway GP; Mendelson J
    Drug Alcohol Depend; 2010 Oct; 111(3):250-6. PubMed ID: 20627425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvinorin A content in legal high products of Salvia divinorum sold in Mexico.
    Hernández-Bello R; García-Rodríguez RV; García-Sosa K; Peña-Rodríguez LM; Vázquez-Hernández M; Ramos-Morales FR; Corcoran O; Sánchez-Medina A
    Forensic Sci Int; 2015 Apr; 249():197-201. PubMed ID: 25710779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
    Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
    Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology.
    Grundmann O; Phipps SM; Zadezensky I; Butterweck V
    Planta Med; 2007 Aug; 73(10):1039-46. PubMed ID: 17628834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvinorin A: from natural product to human therapeutics.
    Vortherms TA; Roth BL
    Mol Interv; 2006 Oct; 6(5):257-65. PubMed ID: 17035666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products.
    Wolowich WR; Perkins AM; Cienki JJ
    Pharmacotherapy; 2006 Sep; 26(9):1268-72. PubMed ID: 16945049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry.
    Medana C; Massolino C; Pazzi M; Baiocchi C
    Rapid Commun Mass Spectrom; 2006; 20(2):131-6. PubMed ID: 16331747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.
    Johnson MW; MacLean KA; Caspers MJ; Prisinzano TE; Griffiths RR
    J Psychopharmacol; 2016 Apr; 30(4):323-9. PubMed ID: 26880225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.